AAPL338.05+8.65 (+2.63%) ▲|ABBV263.40+0.11 (+0.04%) ▲|ABT99.94-1.01 (-1.00%) ▼|ACN182.92+5.80 (+3.27%) ▲|ADBE238.82+5.65 (+2.42%) ▲|AMAT510.18-1.83 (-0.36%) ▼|AMD602.68-4.89 (-0.80%) ▼|AMGN424.43+0.79 (+0.19%) ▲|AMT164.39-1.18 (-0.71%) ▼|AMZN251.25+4.58 (+1.86%) ▲|AVGO353.36-1.74 (-0.49%) ▼|AXP305.20-0.20 (-0.07%) ▼|BA187.09-0.59 (-0.31%) ▼|BAC54.68-0.28 (-0.51%) ▼|BKNG164.43+2.09 (+1.29%) ▲|BLK1,065.81-2.13 (-0.20%) ▼|BMY62.99+0.13 (+0.21%) ▲|BNY146.36-0.62 (-0.42%) ▼|BRK-B500.22-2.13 (-0.42%) ▼|C130.09-0.71 (-0.54%) ▼|CAT814.32-12.32 (-1.49%) ▼|CL86.12-0.34 (-0.39%) ▼|CMCSA21.89+0.29 (+1.32%) ▲|COF194.29-2.17 (-1.10%) ▼|COP126.33+0.89 (+0.71%) ▲|COST918.96-5.63 (-0.61%) ▼|CRM232.14+6.83 (+3.03%) ▲|CSCO108.35+1.41 (+1.32%) ▲|CVS86.14-0.97 (-1.11%) ▼|CVX206.00+1.62 (+0.79%) ▲|DE681.85+2.97 (+0.44%) ▲|DHR223.16-2.55 (-1.13%) ▼|DIS105.52+0.11 (+0.10%) ▲|DUK114.20-0.01 (-0.01%) ▼|EMR156.79-0.46 (-0.29%) ▼|FDX285.50-1.97 (-0.69%) ▼|GD333.79+1.45 (+0.44%) ▲|GE314.43-3.47 (-1.09%) ▼|GEV955.17-7.32 (-0.76%) ▼|GILD150.77-0.51 (-0.34%) ▼|GM77.92-2.55 (-3.17%) ▼|GOOG348.40+11.08 (+3.28%) ▲|GOOGL351.98+11.06 (+3.24%) ▲|GS905.78-10.46 (-1.14%) ▼|HD285.93-2.11 (-0.73%) ▼|HON210.37+0.24 (+0.11%) ▲|IBM220.56+0.57 (+0.26%) ▲|INTC119.47+3.54 (+3.05%) ▲|INTU274.98+6.95 (+2.59%) ▲|ISRG408.19-3.99 (-0.97%) ▼|JNJ267.75+0.18 (+0.07%) ▲|JPM332.67-2.31 (-0.69%) ▼|KO86.79-0.05 (-0.06%) ▼|LIN477.60+4.23 (+0.89%) ▲|LLY1,188.78+4.15 (+0.35%) ▲|LMT511.64-0.57 (-0.11%) ▼|LOW185.82-1.44 (-0.77%) ▼|LRCX326.67+2.81 (+0.87%) ▲|MA557.48-6.10 (-1.08%) ▼|MCD233.07-0.91 (-0.39%) ▼|MDLZ58.12-0.68 (-1.16%) ▼|MDT87.10+0.01 (+0.01%) ▲|META736.55-2.24 (-0.30%) ▼|MMM167.16-1.33 (-0.79%) ▼|MO67.83-0.89 (-1.30%) ▼|MRK147.01-2.27 (-1.52%) ▼|MS190.37-2.39 (-1.24%) ▼|MSFT518.46+9.50 (+1.87%) ▲|MU1,073.79+8.71 (+0.82%) ▲|NEE76.10+0.21 (+0.27%) ▲|NFLX70.11-0.20 (-0.28%) ▼|NKE35.59-0.26 (-0.71%) ▼|NOW134.25+4.31 (+3.32%) ▲|NVDA230.85+3.64 (+1.60%) ▲|ORCL137.34-0.46 (-0.33%) ▼|PEP127.70-0.99 (-0.77%) ▼|PFE28.79+0.07 (+0.23%) ▲|PG146.92-1.40 (-0.94%) ▼|PLTR190.13+3.16 (+1.69%) ▲|PM191.86-2.04 (-1.05%) ▼|QCOM184.67+0.57 (+0.31%) ▲|RTX186.98+0.04 (+0.02%) ▲|SBUX95.06-0.37 (-0.39%) ▼|SCHW98.69-0.41 (-0.41%) ▼|SO83.21-0.24 (-0.29%) ▼|SPG202.73-1.56 (-0.76%) ▼|T24.61+0.13 (+0.53%) ▲|TMO680.68+1.07 (+0.16%) ▲|TMUS163.94+0.96 (+0.59%) ▲|TSLA349.86-2.98 (-0.84%) ▼|TXN281.19-0.50 (-0.18%) ▼|UBER68.96-0.40 (-0.58%) ▼|UNH371.59-3.35 (-0.89%) ▼|UNP274.81+0.66 (+0.24%) ▲|UPS93.70-0.23 (-0.24%) ▼|USB57.71+0.11 (+0.19%) ▲|V362.34-3.55 (-0.97%) ▼|VZ46.11+0.13 (+0.27%) ▲|WFC80.25-0.23 (-0.29%) ▼|WMT105.70-1.11 (-1.03%) ▼|XOM163.65+2.30 (+1.42%) ▲|AAPL338.05+8.65 (+2.63%) ▲|ABBV263.40+0.11 (+0.04%) ▲|ABT99.94-1.01 (-1.00%) ▼|ACN182.92+5.80 (+3.27%) ▲|ADBE238.82+5.65 (+2.42%) ▲|AMAT510.18-1.83 (-0.36%) ▼|AMD602.68-4.89 (-0.80%) ▼|AMGN424.43+0.79 (+0.19%) ▲|AMT164.39-1.18 (-0.71%) ▼|AMZN251.25+4.58 (+1.86%) ▲|AVGO353.36-1.74 (-0.49%) ▼|AXP305.20-0.20 (-0.07%) ▼|BA187.09-0.59 (-0.31%) ▼|BAC54.68-0.28 (-0.51%) ▼|BKNG164.43+2.09 (+1.29%) ▲|BLK1,065.81-2.13 (-0.20%) ▼|BMY62.99+0.13 (+0.21%) ▲|BNY146.36-0.62 (-0.42%) ▼|BRK-B500.22-2.13 (-0.42%) ▼|C130.09-0.71 (-0.54%) ▼|CAT814.32-12.32 (-1.49%) ▼|CL86.12-0.34 (-0.39%) ▼|CMCSA21.89+0.29 (+1.32%) ▲|COF194.29-2.17 (-1.10%) ▼|COP126.33+0.89 (+0.71%) ▲|COST918.96-5.63 (-0.61%) ▼|CRM232.14+6.83 (+3.03%) ▲|CSCO108.35+1.41 (+1.32%) ▲|CVS86.14-0.97 (-1.11%) ▼|CVX206.00+1.62 (+0.79%) ▲|DE681.85+2.97 (+0.44%) ▲|DHR223.16-2.55 (-1.13%) ▼|DIS105.52+0.11 (+0.10%) ▲|DUK114.20-0.01 (-0.01%) ▼|EMR156.79-0.46 (-0.29%) ▼|FDX285.50-1.97 (-0.69%) ▼|GD333.79+1.45 (+0.44%) ▲|GE314.43-3.47 (-1.09%) ▼|GEV955.17-7.32 (-0.76%) ▼|GILD150.77-0.51 (-0.34%) ▼|GM77.92-2.55 (-3.17%) ▼|GOOG348.40+11.08 (+3.28%) ▲|GOOGL351.98+11.06 (+3.24%) ▲|GS905.78-10.46 (-1.14%) ▼|HD285.93-2.11 (-0.73%) ▼|HON210.37+0.24 (+0.11%) ▲|IBM220.56+0.57 (+0.26%) ▲|INTC119.47+3.54 (+3.05%) ▲|INTU274.98+6.95 (+2.59%) ▲|ISRG408.19-3.99 (-0.97%) ▼|JNJ267.75+0.18 (+0.07%) ▲|JPM332.67-2.31 (-0.69%) ▼|KO86.79-0.05 (-0.06%) ▼|LIN477.60+4.23 (+0.89%) ▲|LLY1,188.78+4.15 (+0.35%) ▲|LMT511.64-0.57 (-0.11%) ▼|LOW185.82-1.44 (-0.77%) ▼|LRCX326.67+2.81 (+0.87%) ▲|MA557.48-6.10 (-1.08%) ▼|MCD233.07-0.91 (-0.39%) ▼|MDLZ58.12-0.68 (-1.16%) ▼|MDT87.10+0.01 (+0.01%) ▲|META736.55-2.24 (-0.30%) ▼|MMM167.16-1.33 (-0.79%) ▼|MO67.83-0.89 (-1.30%) ▼|MRK147.01-2.27 (-1.52%) ▼|MS190.37-2.39 (-1.24%) ▼|MSFT518.46+9.50 (+1.87%) ▲|MU1,073.79+8.71 (+0.82%) ▲|NEE76.10+0.21 (+0.27%) ▲|NFLX70.11-0.20 (-0.28%) ▼|NKE35.59-0.26 (-0.71%) ▼|NOW134.25+4.31 (+3.32%) ▲|NVDA230.85+3.64 (+1.60%) ▲|ORCL137.34-0.46 (-0.33%) ▼|PEP127.70-0.99 (-0.77%) ▼|PFE28.79+0.07 (+0.23%) ▲|PG146.92-1.40 (-0.94%) ▼|PLTR190.13+3.16 (+1.69%) ▲|PM191.86-2.04 (-1.05%) ▼|QCOM184.67+0.57 (+0.31%) ▲|RTX186.98+0.04 (+0.02%) ▲|SBUX95.06-0.37 (-0.39%) ▼|SCHW98.69-0.41 (-0.41%) ▼|SO83.21-0.24 (-0.29%) ▼|SPG202.73-1.56 (-0.76%) ▼|T24.61+0.13 (+0.53%) ▲|TMO680.68+1.07 (+0.16%) ▲|TMUS163.94+0.96 (+0.59%) ▲|TSLA349.86-2.98 (-0.84%) ▼|TXN281.19-0.50 (-0.18%) ▼|UBER68.96-0.40 (-0.58%) ▼|UNH371.59-3.35 (-0.89%) ▼|UNP274.81+0.66 (+0.24%) ▲|UPS93.70-0.23 (-0.24%) ▼|USB57.71+0.11 (+0.19%) ▲|V362.34-3.55 (-0.97%) ▼|VZ46.11+0.13 (+0.27%) ▲|WFC80.25-0.23 (-0.29%) ▼|WMT105.70-1.11 (-1.03%) ▼|XOM163.65+2.30 (+1.42%) ▲|
21.2 C
New York
Wednesday, September 30, 2026

Tag: 1

newssourceFORcompanyinformationcontent1releasesmarket

INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Tempus AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit...

SAN DIEGO, June 21, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of Tempus AI, Inc. (NASDAQ: TEM) common stock between August 6, 2024 and May 27, 2025, both dates inclusive (the “Class Period”), have until August 12, 2025 to seek appointment as lead plaintiff of the Tempus AI class action lawsuit. Captioned Shouse v. Tempus AI, Inc., No. 25-cv-06534 (N.D. Ill.), the Tempus AI class action lawsuit charges Tempus AI and certain of Tempus AI’s top executives with violations of the Securities Exchange Act of 1934.

Gan & Lee Pharmaceuticals Presented Multiple Results in Novel Diabetes Therapies at the American Diabetes Association’s 85th Scientific Sessions

In a Phase 2a clinical trial, the GLP-1 RA bofanglutide injection demonstrated a favorable safety and tolerability profile after 23 weeks of once weekly...

BexBack Launches $50 Welcome Bonus and 100% Deposit Match to Empower Crypto Traders with 100x Leverage

SINGAPORE, June 21, 2025 (GLOBE NEWSWIRE) -- BexBack Exchange has launched an aggressive new promotion to empower both new and seasoned crypto traders: a $50 welcome bonus and a 100% deposit match for all new users. As the crypto market braces for another period of high volatility, BexBack is making futures trading more accessible and profitable than ever. With up to 100x leverage, zero KYC requirements, and support for over 50 digital assets, the platform provides an ideal environment for those seeking to capitalize on market swings without large upfront capital.

Gan & Lee Pharmaceuticals Presented Multiple Results in Novel Diabetes Therapies at the American Diabetes Association’s 85th Scientific Sessions

In a Phase 2a clinical trial, the GLP-1 RA bofanglutide injection demonstrated a favorable safety and tolerability profile after 23 weeks of once weekly...

Real Money Online Casinos Canada 2025: Frumzi Expands Live Games Category

Frumzi Casino Has Recently Expanded Its Catalogue of Live Dealer Games, In Order to Become One of the Top Choice Amongst Real Money Online Casinos in Canada for Game Variety 
Frumzi Casino Has Recently Expanded Its Catalogue of Live Dealer Games, In Order to Become One of the Top Choice Amongst Real Money Online Casinos in Canada for Game Variety

Lilly’s oral GLP-1, orforglipron, showed compelling efficacy and a safety profile consistent with injectable GLP-1 medicines, in complete Phase 3 results published in The...

The investigational once-daily pill lowered A1C by an average of 1.3% to 1.6% across doses, with improvements seen as early as four weeks, in adults...

MetaVia Presents Pre-Clinical Data on DA-1241 Demonstrating Additive Hepatoprotective Effects in Combination With Efruxifermin at the ADA’s 85th Scientific Session

CAMBRIDGE, Mass., June 21, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced the presentation of...

New data demonstrates robust efficacy of Vyepti® (eptinezumab) in otherwise difficult-to-treat patients with severe migraine

The full results of the phase IV RESOLUTION trial were presented at the European Academy of Neurology 2025 Annual Congress, where Vyepti® (eptinezumab) demonstrated...

New data demonstrates robust efficacy of Vyepti® (eptinezumab) in otherwise difficult-to-treat patients with severe migraine

The full results of the phase IV RESOLUTION trial were presented at the European Academy of Neurology 2025 Annual Congress, where Vyepti® (eptinezumab) demonstrated...

New data from phase III trial confirms efficacy of Vyepti® (eptinezumab) in Asian population with chronic migraine

The full results of the phase III registrational SUNRISE trial were presented at the European Academy of Neurology 2025 Annual Congress, where eptinezumab demonstrated statistically...

New data from phase III trial confirms efficacy of Vyepti® (eptinezumab) in Asian population with chronic migraine

The full results of the phase III registrational SUNRISE trial were presented at the European Academy of Neurology 2025 Annual Congress, where eptinezumab demonstrated statistically...

ROSEN, LEADING INVESTOR COUNSEL, Encourages Reddit, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RDDT

NEW YORK, June 21, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Reddit, Inc. (NYSE: RDDT) between October 29, 2024 and May 20, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 18, 2025.

ROSEN, LEADING INVESTOR COUNSEL, Encourages Red Cat Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RCAT

NEW YORK, June 21, 2025 (GLOBE NEWSWIRE) --

WHY: New York, N.Y., June 21, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Red Cat Holdings, Inc. (NASDAQ: RCAT) between March 18, 2022 and January 15, 2025, both dates inclusive (the “Class Period”), of the important July 22, 2025 lead plaintiff deadline.

1000 MIGLIA 2025, the fifth and final leg has started

Overtaken yesterday by Erejomovich-Llanos, Vesco-Salvinelli return to the lead with the first Time Trials of the day 
Overtaken yesterday by Erejomovich-Llanos, Vesco-Salvinelli return to the lead with the first Time Trials of the day

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTags1

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers